Recently, a nanoparticle iron supplement, ferumoxytol, was found to have an antileukemia effect in vitro and in vivo in leukemia cells with a low level of ferroportin (FPN) by inducing ferroptosis [14]. The gene discussed is SLC40A1; the disease is leukemia.